latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Wall Street Cheat Street
Sat, 04/27/13 - 10:10 am
Seeking Alpha
Wed, 04/24/13 - 4:46 pm
TheStreet.com
Tue, 04/02/13 - 10:58 am
tags: AbbVie, Achillion, Aegerion, Amarin, Arena Pharmaceuticals, AstraZeneca, Aveo Pharmaceutical, Biogen Idec, Bristol-Myers Squibb, Delcath, Dendreon, Depomed, Gilead, GSK, Merck, NewLink Genetics, Raptor Pharmaceuticals, Rigel, Sangamo BioSciences, Sucampo, Titan Pharmaceuticals, Valeant Pharmaceuticals, Vertex Pharmaceuticals, Vivus, Zogenix
Bizjournals.com
Thu, 03/07/13 - 12:35 pm
Motley Fool
Mon, 03/04/13 - 11:46 am
tags: Aegerion, Breo Ellipta, COPD, Depomed, FDA, GSK, Sarepta, Serada, Theravance
The Motley Fool
Sat, 01/19/13 - 1:12 pm
tags: Aegerion, Astra Zeneca, cancer, Isis Pharmaceuticals, treatment
TheStreet.com
Wed, 01/02/13 - 1:18 pm
Motley Fool
Tue, 01/01/13 - 12:53 pm
tags: Aegerion, Alnylam, Isis Pharmaceuticals, Juxtapid, Kynamro, Lipitor, PCSK9 inhibitors, Pfizer, Regeneron, Sanofi
Yahoo/AP
Mon, 12/24/12 - 11:30 am
Motley Fool
Sat, 12/15/12 - 1:54 pm
Seeking Alpha
Wed, 10/24/12 - 10:58 am
Motley Fool
Sun, 10/21/12 - 10:47 am
Seeking Alpha
Fri, 10/19/12 - 10:57 am
TheStreet.com
Thu, 10/18/12 - 11:39 am
Last 30 twitter posts
-
Fool not as impressed with Aegerion as others are t.co/jRiKxrtStd via @themotleyfool
-
RT @slhoulton: Aegerion stock soars on price boost for cholesterol drug, Juxtapid t.co/zTroU60Kjx
-
Aegerion stock soars on price boost for cholesterol drug, Juxtapid t.co/zTroU60Kjx
-
(AEGR) Aegerion Pharmaceuticals t.co/dveFxJoump
-
Aegerion’s Pricing Power Sends Shares Flying - Particularly interesting with regards to Aegerion’s business mo... t.co/EJEav8DiOf
-
DTN Pharma News: Aegerion Stock Falls On Unusually High Volume (AEGR): t.co/Vxs6ErJuIH
-
Aegerion Pharmaceuticals: #OrphanDrug Juxtapid & Financials t.co/zOg8Roo8r7
-
Aegerion gains on Juxtapid update t.co/feBNaFRcpv
-
Aegerion’s Pricing Power Sends Shares Flying: Shares of Aegerion Pharmaceuticals (NASDAQ: AEGR) rocketed 33% h... t.co/3bqmfHjmm1
-
#Aegerion Reports On Their First Three Months in the Orphan Drug Market t.co/8SHkhi03W2
-
Aegerion Pharmaceuticals Inc. (AEGR) Surged To A New High For The Year t.co/PrZm4Lt25C
-
Aegerion’s Pricing Power Sends Shares Flying t.co/Ml3n4KmvNj $AEGR
-
Conference added: t.co/NTzODcEcA3 - RT @RareDR Aegerion gave a good presentation at Bank of America Healthcare Conference on Wedne...
-
Aegerion gave a good presentation at Bank of America Healthcare Conference on Wednesday....at least Wall Street... t.co/rwxIYHdeKU
-
Aegerion stock soars on price boost for cholesterol drug, Juxtapid t.co/s94womtZMP
-
Aegerion Pharmaceuticals Inc. (AEGR) Surged To A New High For The Year t.co/N7tP5BZ0Pa RTT
-
Aegerion stock soars on price boost for cholesterol drug, Juxtapid #Boston t.co/4fMXsFXCQ5
-
Aegerion stock soars on price boost for cholesterol drug, Juxtapid - Boston Business Journal (blog) t.co/NOxUGHqZv2
-
#Aegerion Pharmaceuticals destined for a plunge? MACD is negative.
-
Aegerion Expects $1 Billion In Sales t.co/97Nrzw1jpn $AEGR
-
Market News: Tesla Motors, Cisco, Infinity Pharma, Aegerion, Kohl’s: Post Market News Stocks that were active ... t.co/kv9crYOwgS
-
Aegerion stock soars on price boost for cholesterol drug, Juxtapid: Shares of Aegerion Pharmaceuticals... t.co/i7WlMOADlX
-
[Boston Biz Jrnl] Aegerion stock soars on price boost for cholesterol drug, Juxtapid t.co/qQ1sq0FTjM
-
[Boston Biz Jrnl] Aegerion stock soars on price boost for cholesterol drug, Juxtapid t.co/qvx1yM9EmW
-
Aegerion stock soars on price boost for cholesterol drug, Juxtapid: Shares of Aegerion Pharmaceuticals (Nasdaq... t.co/irz4z5kKZQ
-
Business| Aegerion stock soars on price boost for cholesterol drug, Juxtapid: Shares of Aegerion Pharmaceutica... t.co/nLBpT4RT5B
-
Today's Winners: Aegerion +30.6% $AEGR Halozyme +18.4% $HALO Adv Cell Tech +16.3% $ACTC Neuralstem +12.3% $CUR Marina +7.7% $MRNA
-
DTN Pharma News: Aegerion surges after bullish projection on Juxtapid potential: t.co/H3A7Vrofjv
-
$AEGR Aegerion surges after bullish projection on Juxtapid potential: Full Story t.co/gj3kdNZC1v
-
Aegerion Pharmaceuticals $AEGR spokesperson says company has no immediate plan to raise funds through secondary offering $$ #stocks
